Catalyst Crew Technologies Corp. (CCTC) presents a textbook zero-asset, fully-consumed liquidation posture as of December 31, 2025. Total assets are $0 on a GAAP basis — cash is $0, no receivables, no inventory, no PP&E, no capitalized intangibles. Under the liquidation lens, haircutted asset recovery is therefore also $0. Against this, total liabilities stand at $630,860, all current, comprising: accounts payable and accrued liabilities of $235,923; third-party notes payable of $272,304 (demand, 10% interest, 39 individual promissory notes); related-party notes payable of $88,042 (demand, 10%); and convertible notes payable of $34,591. All liabilities are due on demand or current; there is no long-term debt tranche. Net recovery to equity in liquidation is negative $630,860, with zero prospect of partial creditor recovery from asset proceeds. This figure is unchanged from the MFFAIS CLV/LLV/OLV of -$630,860. Compared to the prior filing (10-Q for Q3 2025, September 30, 2025), total liabilities were $663,514 at that date per MD&A disclosure in that filing; the year-end balance of $630,860 reflects a modest reduction, primarily explained by $150,200 in equity raised via sale of 15,020,000 common shares during Q4 2025, which funded operating cash outflows rather than debt repayment — notes payable actually increased from $216,713 (December 31, 2024) to $272,304 (December 31, 2025) as $55,591 in new promissory notes were issued. The $29.6M accumulated deficit dwarfs the $28.97M of combined paid-in capital and par value, but this has no liquidation relevance given zero tangible assets. Post-period, on February 17, 2026, a change-of-control transaction occurred: new CEO Kevin Rodan Levy acquired majority control and the Company acquired AI-enabled healthcare technology assets in exchange for 12,000,000 restricted shares. The acquired assets are discussed in MD&A and Note 10 as 'artificial intelligence-enabled healthcare analytics platform' assets, but the filing does not separately tag or value any intangible asset on the balance sheet as of December 31, 2025; under the liquidation lens, such assets would be assigned $0 recovery regardless. The filing carries a going-concern qualification from auditor Beckles & Co. Inc. (PCAOB ID 7116). Internal controls are assessed as ineffective due to lack of segregation of duties. Operating expenses for 2025 were $171,852, driven by G&A of $149,450 and professional fees of $22,402, with $0 revenue in both 2025 and 2024.
▼ Community Notes